Celliance Offers Australian-Sourced Probumin(TM) Plus Bovine Albumin.ATLANTA -- Serologicals Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : SERO SERO Southeast Regional Office SERO Sekundaerrohstoffe (recycling, former GDR) SERO Syringe Exchange Resources Online SERO System Engineering/Engineer Release Order SERO Site Emergency Response Organisation (nuclear) ) announced today that Celliance, its wholly-owned subsidiary, is launching a new Bovine Albumin manufactured exclusively from animals originating in the country of Australia. Probumin(TM) Plus Albumin is a high-quality albumin product manufactured from Australian-sourced material. Celliance has developed this material in order to incorporate the qualities of its premium albumin grades with the benefits of sourcing the raw material from Australia, a country classified as BSE-free (Bovine Spongiform spongiform /spon·gi·form/ (spun´ji-form) resembling a sponge. spon·gi·form adj. Resembling a sponge, as in appearance or porosity. spongiform resembling a sponge. Encephalopathy-free). "The market has been indicating an interest in a high quality product that originates from a BSE-free country. Australian-sourced material provides such a profile and as the largest manufacturer of BSA 1. BSA - Business Software Alliance. 2. BSA - Bidouilleurs Sans Argent. worldwide, Celliance is able to offer a high quality material to our customers," said David L. Bellitt, President of Celliance. Probumin(TM) Plus is the latest offering in Celliance's line of bovine albumin products. Customers will be able to choose by application, by specification and now by material source as Probumin(TM) Plus joins the 30 other grades of Albumin that we offer. Celliance strives to provide products of the highest quality and safety through strict material sourcing specifications and proprietary prion prion (prī`ŏn), infectious agent thought to cause a group of diseases known as prion diseases or transmissible spongiform encephalopathies. and viral clearance processes. In addition, all Probumin(TM) products are screened for adventitious ADVENTITIOUS, adventitius. From advenio; what comes incidentally; us adventitia bona, goods that, fall to a man otherwise than by inheritance; or adventitia dos, a dowry or portion given by some other friend beside the parent. viruses per the 9CFR CFR See: Cost and Freight 113.5(C), cytopathic effects and mycoplasma mycoplasma Any of the bacteria that make up the genus Mycoplasma. They are among the smallest of bacterial organisms. The cell varies from a spherical or pear shape to that of a slender branched filament. to eliminate concerns stemming from regulatory and safety issues. Celliance offers an expanding array of bioprocessing products and services including diagnostic products, contract research and manufacturing services, and cell culture media supplements. Key products include: EX-CYTE(R), the largest selling cell growth supplement; Probumin(TM), a proprietary line of bovine albumin; and Incelligent(TM), the Company's recombinant human insulin Noun 1. recombinant human insulin - a form of insulin (trade name Humulin) made from recombinant DNA that is identical to human insulin; used to treat diabetics who are allergic to preparations made from beef or pork insulin Humulin . It is also the world's leading provider of monoclonal antibodies for the blood typing industry. Celliance is a Serologicals company based in Atlanta, GA. Serologicals Corporation, headquartered in Atlanta, Georgia, is a global provider of biological products, enabling technologies and services to a diverse customer base that includes major life science companies and leading research institutions. Our customers use our products, technologies and services in a wide variety of their activities, including basic research, drug discovery, diagnosis and biomanufacturing. Our products, technologies and services are essential tools for research in key disciplines, including neurology, oncology, hematology, immunology, cardiology, proteomics, infectious diseases, cell signaling and molecular biology. In addition, the Company is the world's leading provider of monoclonal antibodies for the blood typing industry. Serologicals has more than 1,000 employees worldwide, and its shares are traded on the NASDAQ national stock market under the symbol SERO. For more information, please visit our websites: www.serologicals.com and www.celliancecorp.com. Serologicals is a registered trademark of Serologicals Royalty Company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion